Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2009
12/30/2009EP2138583A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
12/30/2009EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications
12/30/2009EP2138511A1 HER3 as a determinant for the prognosis of melanoma
12/30/2009EP2138510A1 Methods of generating antibodies against cytokines
12/30/2009EP2138509A1 Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules
12/30/2009EP2138508A1 Met agonists
12/30/2009EP2138505A1 Method for producing soluble thrombomodulin of high purity
12/30/2009EP2138195A2 IFBM's to promote attachment of target analytes
12/30/2009EP2138192A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent
12/30/2009EP2138158A1 Hair growth-inhibiting agent
12/30/2009EP2137530A2 Antagonists of bitter taste receptors and uses thereof
12/30/2009EP2137305A1 Engineered versions of cgtb (beta-1,3- galactosyltransferase) enzymes, with enhanced enzymatic properties
12/30/2009EP2137302A2 Corn plants and seed enhanced for asparagine and protein
12/30/2009EP2137292A1 Peptide mixture as wine stabiliser
12/30/2009EP2137213A1 Methods and compositions for treating prostate cancer
12/30/2009EP2137212A2 Mannoprotein liquid formulations
12/30/2009EP2137204A1 Use of substrates as pharmacological chaperones
12/30/2009EP2136836A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
12/30/2009EP2136831A2 Anti-angiogenic peptides
12/30/2009EP2136824A1 Use of selected lactic acid bacteria for reducing atherosclerosis
12/30/2009EP2049566B1 G-csf site-specific mono-conjugates
12/30/2009EP1689432B1 Compositions and methods for the treatment of tumor of hematopoietic origin
12/30/2009EP1618380B1 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION
12/30/2009EP1530642B1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
12/30/2009EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications
12/30/2009EP1438325B1 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
12/30/2009EP1409482B1 Dye-sulfenates for dual phototherapy
12/30/2009EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
12/30/2009EP1066394B1 Novel basal endosperm transfer cell layer (betl) specific genes
12/30/2009EP0804561B1 Regulated transcription of targeted genes and other biological events
12/30/2009CN101616931A Smoothened多肽及使用方法 Smoothened polypeptide and methods of use
12/30/2009CN101616930A Method of purification of hydrophobic proteins
12/30/2009CN101616929A Peptide-complement conjugates
12/30/2009CN101613705A Optimizing glycan processing in plants
12/30/2009CN101613408A Method for separating and detecting whey proteins
12/30/2009CN101613407A Modified trout protamine
12/30/2009CN101613406A Genes and polypeptides relating to human colon cancers
12/30/2009CN101613405A Genes and polypeptides relating to human colon cancers
12/30/2009CN101613404A Method for separating and purifying green malt antimicrobial protein
12/30/2009CN101613403A Method for preparing antimicrobial protein by using malt protein of barley
12/30/2009CN101613402A Surface protein of streptococcus suis 2-type and preparation method and application thereof
12/30/2009CN101613401A Nucleic acid enzyme surface protein of streptococcus suis 2-type and preparation method and application thereof
12/30/2009CN101613400A Surface cytoderm protein of streptococcus suis 2-type and preparation method and application thereof
12/30/2009CN101613399A Surface protein of streptococcus suis type-2, preparation method thereof and application
12/30/2009CN101613398A Surface lipoprotein of streptococcus suis type-2, preparation method thereof and application
12/30/2009CN101613397A Neisserial antigenic peptides
12/30/2009CN100575493C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/30/2009CN100575360C Human liver regeneration enhancer with high activity and its preparation method
12/30/2009CN100575359C Rana grahami boulenger antibiotic peptide and application thereof
12/30/2009CA2729294A1 Toxin genes and methods for their use
12/30/2009CA2729105A1 Attenuated pestivirus
12/30/2009CA2729100A1 Methods for dosing an activin-actriia antagonist and monitoring of treated patients
12/30/2009CA2729096A1 Methods for dosing an actriib antagonist and monitoring of treated patients
12/30/2009CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels
12/30/2009CA2728933A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009CA2728734A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/30/2009CA2728708A1 Factor viii muteins with reduced immunogenicity
12/30/2009CA2728511A1 Sulfonamide compounds or salts thereof
12/30/2009CA2728358A1 Storage-stable, functionally intact fibrinogen
12/30/2009CA2728047A1 A process of purifying coagulation factor viii
12/30/2009CA2728038A1 Novel immunoadjuvant flagellin-based compounds and use thereof
12/30/2009CA2728012A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009CA2727310A1 Plants having enhanced yield-related traits and a method for making the same
12/30/2009CA2726894A1 Therapeutic agents comprising elastin-like peptides
12/30/2009CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
12/30/2009CA2726054A1 Method of producing yeast biomass
12/30/2009CA2714940A1 Her3 as a determinant for the prognosis of melanoma
12/29/2009US7638694 Plants and seeds of hybrid corn variety CH944969
12/29/2009US7638693 Plants and seeds of hybrid corn variety CH120555
12/29/2009US7638692 Plants and seeds of hybrid corn variety CH538026
12/29/2009US7638681 Auxin transport proteins
12/29/2009US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver.
12/29/2009US7638618 Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
12/29/2009US7638614 Xenobiotic related induction of gene expression
12/29/2009US7638613 For use in the treatment of paper pulp, stable over wide temperature and pH range
12/29/2009US7638612 Compositions and methods for cDNA synthesis
12/29/2009US7638608 Assay for the separation and quantification of hemagglutinin antigens
12/29/2009US7638607 Urocortin proteins and uses thereof
12/29/2009US7638604 Monoclonal antibodies against interleukin-22
12/29/2009US7638603 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
12/29/2009US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
12/29/2009US7638601 Transient receptor potential channel TRPM8 and its use
12/29/2009US7638600 identification and characterization of environmental bacteriophages infecting Bacillus anthracis, including enzymes, fusion proteins
12/29/2009US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery
12/29/2009US7638598 ErbB interface peptidomimetics and methods of use thereof
12/29/2009US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
12/29/2009US7638498 Substances for preventing and treating autoimmune diseases
12/29/2009US7638495 inhibiting precipitation; bone morphogenic proteins
12/29/2009US7638494 G-type peptides to ameliorate atherosclerosis
12/29/2009US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
12/29/2009US7638490 For treating anorexia or cachexia
12/29/2009US7638489 Modulation of angiogenesis by Bartonella henselae
12/29/2009US7638486 administering a first peptide comprising 10 to 50 amino acid residues and a second protein selected from bone morphogenic proteins, transforming growth, epidermal growth, epithelial cell growth, fibroblast growth, platelet derived growth or insulin-like growth factors, to enhance regeneration of bones
12/29/2009US7638485 Modulating apoptosis
12/29/2009US7638481 With vaccinia virus complement control protein, poxvirus encoded
12/29/2009US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
12/29/2009US7638333 Anthrax vaccine
12/29/2009US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells